Showing results (221-230 of 824) with videos related to
Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
Facts and Hopes in Multiple Myeloma ImmunotherapyAdam S Sperling, Kenneth C AndersonBlood Cancer Discovery|October 18, 2021
Don't Compromise Myeloma Care Due to COVID-19 Pandemic!Nikhil C Munshi, Kenneth C AndersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Immune Therapies in Multiple MyelomaShaji K Kumar, Kenneth C AndersonImmunotherapy|September 16, 2015
Targeting B-cell maturation antigen in multiple myelomaYu-Tzu Tai, Kenneth C AndersonHematology. American Society of Hematology. Education Program|December 4, 2018
Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologistTanya M Wildes, Kenneth C AndersonCritical Reviews in Oncology/Hematology|May 15, 2002
What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?Richard J Benjamin, Kenneth C AndersonBlood Cancer Discovery|October 18, 2021
Blood Cancer Discovery Turns OneRiccardo Dalla-Favera, Kenneth C AndersonExpert Opinion on Biological Therapy|July 7, 2019
B cell maturation antigen (BCMA)-based immunotherapy for multiple myelomaYu-Tzu Tai, Kenneth C AndersonCancer Cell|November 16, 2005
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from BortezomibDharminder Chauhan, Laurence Catley, Guilan Li, et al.Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C AndersonPageof 83